Hu Dehong, Zhang Jingnan, Gao Guanhui, Sheng Zonghai, Cui Haodong, Cai Lintao
1. Guangdong Key Laboratory of Nanomedicine, CAS Key Laboratory of Health Informatics, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P.R. China;; 2. Paul C. Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China.
1. Guangdong Key Laboratory of Nanomedicine, CAS Key Laboratory of Health Informatics, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P.R. China;
Theranostics. 2016 Apr 28;6(7):1043-52. doi: 10.7150/thno.14566. eCollection 2016.
Photoacoustic (PA) imaging and photothermal therapy (PTT) as light-induced theranostic platforms have been attracted much attention in recent years. However, the development of highly efficient and integrated phototheranostic nanoagents for amplifying PA imaging and PTT treatments poses great challenges. Here, we report a novel phototheranostic nanoagent using indocyanine green-loaded polydopamine-reduced graphene oxide nanocomposites (ICG-PDA-rGO) with amplifying PA and PTT effects for cancer theranostics. The results demonstrate that the PDA layer coating on the surface of rGO could effectively absorb a large number of ICG molecules, quench ICG's fluorescence, and enhance the PDA-rGO's optical absorption at 780 nm. The obtained ICG-PDA-rGO exhibits stronger PTT effect and higher PA contrast than that of pure GO and PDA-rGO. After PA imaging-guided PTT treatments, the tumors in 4T1 breast subcutaneous and orthotopic mice models are suppressed completely and no treatment-induced toxicity being observed. It illustrates that the ICG-PDA-rGO nanocomposites constitute a new class of theranostic nanomedicine for amplifying PA imaging and PTT treatments.
近年来,光声(PA)成像和光热疗法(PTT)作为光诱导的诊疗平台备受关注。然而,开发用于增强PA成像和PTT治疗的高效集成光诊疗纳米剂面临巨大挑战。在此,我们报道了一种新型光诊疗纳米剂,它使用负载吲哚菁绿的聚多巴胺还原氧化石墨烯纳米复合材料(ICG-PDA-rGO),具有增强的PA和PTT效应,用于癌症诊疗。结果表明,rGO表面的PDA层能够有效吸收大量ICG分子,淬灭ICG的荧光,并增强PDA-rGO在780nm处的光吸收。所获得的ICG-PDA-rGO比纯GO和PDA-rGO表现出更强的PTT效应和更高的PA对比度。在PA成像引导的PTT治疗后,4T1乳腺皮下和原位小鼠模型中的肿瘤被完全抑制,且未观察到治疗引起的毒性。这表明ICG-PDA-rGO纳米复合材料构成了一类用于增强PA成像和PTT治疗的新型诊疗纳米药物。